Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Xeomin for allergic and intrinsic rhinitis
2009-017048-15Phase 2Completed
- Sponsor
- Universitätsmedizin Göttingen
- Start
- Feb 2010
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of botulinum toxin type A in allergic rhinitis (AR) and non-allergic rhinitis (NAR) (3 arms), sponsored by Universitätsmedizin Göttingen. Started Feb 2010; status: completed.
02
Drugs
botulinum toxin type A
03
Conditions
allergic rhinitis (AR)non-allergic rhinitis (NAR)
Beyond the preview
Go deeper on 2009-017048-15.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2009-017048-15.